Case Study 6: The Diagnostic Challenge of a 75-Year-Old Man Who Had, Then Didn’t Have, Then Did Have Alzheimer’s Disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Case Study 6: The Diagnostic Challenge of a 75-Year-Old Man Who Had, Then Didn’t Have, Then Did Have Alzheimer’s Disease
Authors
Keywords
-
Journal
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
Volume 35, Issue 4, Pages 325-332
Publisher
American Psychiatric Association Publishing
Online
2023-10-16
DOI
10.1176/appi.neuropsych.20230097
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
- (2022) Peter T. Nelson et al. ACTA NEUROPATHOLOGICA
- Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers
- (2022) Michael Tran Duong et al. Current Neurology and Neuroscience Reports
- Influence of Cognitive Reserve on Cognitive Trajectories: Role of Brain Pathologies
- (2021) Xuerui Li et al. NEUROLOGY
- Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study
- (2021) Adam J. Dugan et al. Acta Neuropathologica Communications
- Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
- (2021) Charlotte E Teunissen et al. LANCET NEUROLOGY
- Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging Brain
- (2020) Richard A. Hickman et al. Current Neurology and Neuroscience Reports
- Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology
- (2020) Hyun-Sik Yang et al. NEURON
- Diagnostic Accuracy of Amyloid versus 18 F‐Fluorodeoxyglucose Positron Emission Tomography in Autopsy‐Confirmed Dementia
- (2020) Orit H. Lesman‐Segev et al. ANNALS OF NEUROLOGY
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
- (2019) Peter T Nelson et al. BRAIN
- Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
- (2019) Arno de Wilde et al. Alzheimers Research & Therapy
- Evidence-based Interpretation of Amyloid-β PET Results
- (2018) David Bergeron et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
- (2018) John L Robinson et al. BRAIN
- Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study
- (2018) Hyun-Sik Yang et al. LANCET NEUROLOGY
- How early can we diagnose Alzheimer disease (and is it sufficient)?
- (2018) Ronald C. Petersen NEUROLOGY
- Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43
- (2018) Alexandra M. Wennberg et al. JAMA Neurology
- Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study
- (2017) Keith A Josephs et al. LANCET NEUROLOGY
- TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD
- (2017) Sukriti Nag et al. NEUROLOGY
- Correlation of florbetaben PET imaging and the amyloid peptide Aß42 in cerebrospinal fluid
- (2017) Carola G. Schipke et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Suspected non-Alzheimer disease pathophysiology — concept and controversy
- (2016) Clifford R. Jack et al. Nature Reviews Neurology
- The TMEM106B locus and TDP-43 pathology in older persons without FTLD
- (2015) L. Yu et al. NEUROLOGY
- Diagnostic Criteria for Vascular Cognitive Disorders
- (2014) Perminder Sachdev et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition
- (2014) Effie M Mitsis et al. Molecular Neurodegeneration
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
- (2013) Keith A. Johnson et al. Alzheimers & Dementia
- Brain Imaging in Alzheimer Disease
- (2013) K. A. Johnson et al. Cold Spring Harbor Perspectives in Medicine
- The Neuropsychological Profile of Alzheimer Disease
- (2013) S. Weintraub et al. Cold Spring Harbor Perspectives in Medicine
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
- (2011) Melissa E Murray et al. LANCET NEUROLOGY
- Neuropathologic Correlates of Hippocampal Atrophy in the Elderly: A Clinical, Pathologic, Postmortem MRI Study
- (2011) Robert J. Dawe et al. PLoS One
- Argyrophilic grain disease
- (2008) I. Ferrer et al. BRAIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now